Recent Updates
Recently added Catalysts
CLNN Positive Sentiment

Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Tuesday, September 3, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Clene Inc. has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference, set to take place on September 9, 2024. The company, which specializes in treatments for neurodegenerative diseases, will present virtually at 7:00 am EST. Investors can also schedule one-on-one meetings with company management. A webcast of the presentation will be available on Clene's website.
Price reaction · baseline $5.27 (2024-08-30 close) · hit after-hours · clean, no other CLNN news in the window
day 0 close
+12.3%
day 1 · peak
+26.4%
day 3
+12.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Clene is actively engaging with investors at a significant conference.
  • The company focuses on important areas like mitochondrial health and neurodegenerative diseases.
  • The presentation format allows for broader access via a virtual platform.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+63%
120-day peak, hindsight
Typical move
5.3%
average across 6 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
CNMAu8
Phase 2 · Amyotrophic Lateral Sclerosis

Full Press Release Details

SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that management will present at the H.C. Wainwright 26th Annual Global Investment Conference and host 1x1 investor meetings.
Date: September 9, 2024
Time of Presentation: 7:00 am EST
Format: Virtual Presentation
1x1 Meetings: Please contact your H.C. Wainwright representative
A webcast of the presentation will be available on the “Events” section of the Clene website. Alternatively, one can register online to view the webcast here: link.

Frequently Asked Questions

What is Clene Inc. focused on?

Clene Inc. focuses on enhancing mitochondrial health and protecting neuronal function.

When is Clene's presentation at the conference?

Clene's presentation is on September 9, 2024, at 7:00 am EST.

How can I view Clene's webcast presentation?

You can view Clene's webcast in the 'Events' section of their website.

What diseases does Clene aim to treat?

Clene aims to treat neurodegenerative diseases like ALS and MS.

Who should I contact for 1x1 meetings with Clene?

Please contact your H.C. Wainwright representative for 1x1 meetings.

ShareAdd on Google
Tags: CLNN Viatris Investor Conferences Healthcare Clene neurodegenerative diseases H.C. Wainwright investment conference
Last updated: Sep 3, 2024

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~11 mo
Medium dilution risk
Lead asset
CNMAu8Phase 2
Amyotrophic Lateral Sclerosis →

Catalyst track record

+63%
best trade around CLNN's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CLNN.

See every catalyst's timing & PoA →